Furthermore, numerous well recognized adverse prognostic markers, such as U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, lost their detrimental effect in people taken care of with VO. The only variable that remained predictive of a shorter development-cost-free survival During this cohort of clie